Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

593 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prospective evaluation of the prognostic value of immune-related adverse events in patients with non-melanoma solid tumour treated with PD-1/PD-L1 inhibitors alone and in combination with radiotherapy.
Schweizer C, Schubert P, Rutzner S, Eckstein M, Haderlein M, Lettmaier S, Semrau S, Gostian AO, Frey B, Gaipl US, Zhou JG, Fietkau R, Hecht M. Schweizer C, et al. Among authors: hecht m. Eur J Cancer. 2020 Nov;140:55-62. doi: 10.1016/j.ejca.2020.09.001. Epub 2020 Oct 9. Eur J Cancer. 2020. PMID: 33045663 Clinical Trial.
Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors.
Griewing LM, Schweizer C, Schubert P, Rutzner S, Eckstein M, Frey B, Haderlein M, Weissmann T, Semrau S, Gostian AO, Müller SK, Traxdorf M, Iro H, Zhou JG, Gaipl US, Fietkau R, Hecht M. Griewing LM, et al. Among authors: hecht m. BMC Cancer. 2021 Mar 24;21(1):314. doi: 10.1186/s12885-021-08006-0. BMC Cancer. 2021. PMID: 33761922 Free PMC article.
Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck Cancer.
Semrau S, Gostian AO, Traxdorf M, Eckstein M, Rutzner S, von der Grün J, Illmer T, Hautmann M, Klautke G, Laban S, Brunner T, Tamaskovics B, Frey B, Zhou JG, Geppert CI, Hartmann A, Balermpas P, Budach W, Gaipl U, Iro H, Fietkau R, Hecht M. Semrau S, et al. Among authors: hecht m. Cancers (Basel). 2021 Apr 19;13(8):1959. doi: 10.3390/cancers13081959. Cancers (Basel). 2021. PMID: 33921668 Free PMC article.
[Therapies for synchronous malignomas - the importance of interdisciplinary oncology].
Müller S, Haderlein M, Traxdorf M, Semrau S, Agaimy A, Lettmaier S, Gostian AO, Schubart C, Mantsopoulos K, Schmidt D, Wiesmueller M, Sievert M, Beck M, Eckstein M, Fietkau R, Iro H, Hecht M. Müller S, et al. Among authors: hecht m. Laryngorhinootologie. 2022 Apr;101(4):327-330. doi: 10.1055/a-1540-7017. Epub 2021 Jul 23. Laryngorhinootologie. 2022. PMID: 34298563 German. No abstract available.
Hypofractionated Radiotherapy Upregulates Several Immune Checkpoint Molecules in Head and Neck Squamous Cell Carcinoma Cells Independently of the HPV Status While ICOS-L Is Upregulated Only on HPV-Positive Cells.
Wimmer S, Deloch L, Hader M, Derer A, Grottker F, Weissmann T, Hecht M, Gostian AO, Fietkau R, Frey B, Gaipl US. Wimmer S, et al. Among authors: hecht m. Int J Mol Sci. 2021 Aug 24;22(17):9114. doi: 10.3390/ijms22179114. Int J Mol Sci. 2021. PMID: 34502022 Free PMC article.
Reduction of Elective Radiotherapy Treatment Volume in Definitive Treatment of Locally Advanced Head and Neck Cancer-Comparison of a Prospective Trial with a Revised Simulated Contouring Approach.
Weissmann T, Speer S, Putz F, Lettmaier S, Schubert P, Shariff M, Semrau S, Gostian AO, Traxdorf M, Mueller SK, Eckstein M, Hautmann M, von der Grün J, Haderlein M, Frey B, Gaipl US, Bert C, Iro H, Fietkau R, Hecht M. Weissmann T, et al. Among authors: hecht m. J Clin Med. 2021 Oct 11;10(20):4653. doi: 10.3390/jcm10204653. J Clin Med. 2021. PMID: 34682782 Free PMC article.
593 results